Providing GLP-1 drugs to 19.7 million Medicare beneficiaries with obesity would cost $268 billion a year, researchers estimate in a recent study
A sensitivity analysis accounting for factors such as demographics, starting BMI classification, residence in a socially vulnerable area, comorbidities, and baseline HbA1c level also found that patients on GLP-1s were more likely to experience weight loss and to reduce their HbA1c levels
Stay well-hydrated by sipping water throughout the day, as adequate hydration helps prevent constipation and may reduce nausea
The early dosing rules differ slightly between the two, even though the active ingredient is identical
is co-founder and shareholder of ROSCUE Therapeutics GmbH
Bunck MC, Corner A, Eliasson B, et al